In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
386 News Items found
Four dogs wearing blue bandanas are held on leashes in a hallway at Memorial Hospital. Three handlers are seen only from the waist down.
Feature
Top Dogs: Meet MSK’s Four-Legged Volunteers

The Caring Canines program at Memorial Sloan Kettering has been going strong for more than 12 years.
an illustration of a cigarette burning and smoke entering lungs
Feature
How Do Cigarettes Cause Cancer?

Everyone knows that cigarettes cause cancer. But what do we know about how they do it?
Giovanna Whitting
For Thyroid Cancers with RET Mutations, FDA Approves Selpercatinib

The FDA has granted full approval to the targeted therapy selpercatinib (Retevmo®) for treating thyroid cancers that have certain changes in a gene called RET. Learn about MSK’s role in the development of this drug and about how patients may benefit.
Joan Massagué
How Cancer Spreads: Four Emerging Insights About Metastasis

Sloan Kettering Institute Director Dr. Joan Massagué talks about our updated understanding of cancer metastasis.
MSK helped Roberto Romero’s immune system grow an army of T cells to fight melanoma using TIL therapy, which offers new hope against solid tumors.
How MSK Used TIL Therapy To Treat Melanoma in Roberto

Learn how MSK uses TIL therapy for melanoma — the first cell therapy approved by the FDA to treat a solid tumor.
AACR sign
At AACR, MSK Researchers Spotlight Health Disparities and Propose Solutions

Topics included more diverse representation in clinical trials, racial disparities in colorectal cancer, and ancestry testing to improve diagnoses.
Harini Veeraraghavan stands in front of a radiology display
How MSK Doctors Are Using AI To Improve Radiation Treatment

MSK researchers are leading the development of new artificial intelligence (AI) models to improve the targeting of radiation therapy — teaching computers to better isolate tumors and spare more of the surrounding healthy tissue.
Mamadou Diallo
Personal Perspective: Diversity and Inclusion at MSK

Learn about diversity and inclusion at Memorial Sloan Kettering, as people from across MSK share their insights and personal experiences.
Richard Nixon with Benno and Nancy Schmidt
Mission Possible? Revisiting the ‘War on Cancer’ 50 Years Later

In 1971, Richard Nixon launched a “war on cancer.” It’s still raging.
An illustration of CRISPR-Cas9
In the Lab
A Cut Above: MSK-Developed Software Makes CRISPR More Precise

A freely accessible software program provides researchers with an easy way to optimize a popular genome-editing tool.